Cell Transplantation SCIE

國際簡稱：CELL TRANSPLANT 參考譯名：細(xì)胞移植

主要研究方向：生物-細(xì)胞與組織工程非預(yù)警期刊審稿周期：約1月

《細(xì)胞移植》(Cell Transplantation)是一本由SAGE Publications Inc.出版的以生物-細(xì)胞與組織工程為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。

4區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
104 年發(fā)文量
3.2 IF影響因子
開放是否OA
90 H-index
1992 創(chuàng)刊年份
Bimonthly 出版周期
English 出版語言

Cell Transplantation, The Regenerative Medicine Journal is an open access, peer reviewed journal that is published 12 times annually. Cell Transplantation is a multi-disciplinary forum for publication of articles on cell transplantation and its applications to human diseases. Articles focus on a myriad of topics including the physiological, medical, pre-clinical, tissue engineering, stem cell, and device-oriented aspects of the nervous, endocrine, cardiovascular, and endothelial systems, as well as genetically engineered cells. Cell Transplantation also reports on relevant technological advances, clinical studies, and regulatory considerations related to the implantation of cells into the body in order to provide complete coverage of the field.

[ 查看全部 ]

投稿咨詢加急咨詢

Cell Transplantation期刊信息

ISSN：0963-6897
出版語言：English
是否OA：開放
E-ISSN：1555-3892
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：SAGE Publications Inc.
出版周期：Bimonthly
創(chuàng)刊時間：1992
開源占比：0.9569
Gold OA文章占比：95.50%
OA被引用占比：1
出版國人文章占比：0.29
出版撤稿占比：0
研究類文章占比：79.81%

Cell Transplantation CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

0.701

0.625

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Transplantation	Q2	15 / 54	73%
大類：Medicine 小類：Biomedical Engineering	Q2	114 / 303	62%
大類：Medicine 小類：Cell Biology	Q3	166 / 285	41%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Cell Transplantation中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植	4區(qū) 4區(qū) 4區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植	4區(qū) 4區(qū) 4區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植 CELL & TISSUE ENGINEERING 細(xì)胞與組織工程	3區(qū) 3區(qū) 4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CELL & TISSUE ENGINEERING 細(xì)胞與組織工程 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植	4區(qū) 3區(qū) 3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植 CELL & TISSUE ENGINEERING 細(xì)胞與組織工程	3區(qū) 3區(qū) 4區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 TRANSPLANTATION 移植 CELL & TISSUE ENGINEERING 細(xì)胞與組織工程	3區(qū) 3區(qū) 4區(qū)

Cell Transplantation JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q3	19 / 31	40.3%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	81 / 189	57.4%
學(xué)科：TRANSPLANTATION	SCIE	Q2	10 / 31	69.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL & TISSUE ENGINEERING	SCIE	Q3	16 / 31	50%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	74 / 189	61.11%
學(xué)科：TRANSPLANTATION	SCIE	Q2	13 / 31	59.68%

Cell Transplantation歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Cell Transplantation中國學(xué)者發(fā)文選摘

1、circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response
Author: Zhang, Yinglang; Li, Zhi; Zhang, Yu; Shen, Chong; Zhang, Zhe; Ren, Xiaolei; Guo, Changgang; Yang, Shaobo; Wang, Zejin; Hu, Hailong

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231165874
2、Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6
Author: Wang, Jiantao; Yang, Chuan; Cao, Huan; Yang, Jianwang; Meng, Wenxia; Yu, Miaomiao; Yu, Lei; Wang, Baoshan

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231154574
3、Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization
Author: Shigyo, Michiko; Kobayashi, Yoshiomi; Platoshyn, Oleksandr; Marsala, Silvia; Kato Jr, Tomohisa; Takamura, Naoki; Yoshida, Kenji; Kishino, Akiyoshi; Bravo-Hernandez, Mariana; Juhas, Stefan; Juhasova, Jana; Studenovska, Hana; Proks, Vladimir; Ciacci, Joseph D.; Marsala, Martin

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231163232
4、Human Menstrual Blood-Derived Endometrial Stem Cells Promote Functional Recovery by Improving the Inflammatory Microenvironment in a Mouse Spinal Cord Injury Model
Author: Shi, Yaping; Liu, Yunfei; Zhang, Bichao; Li, Xiaoying; Lin, Juntang; Yang, Ciqing

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231154579
5、Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant
Author: Li, Qing; Lyu, Cuicui; Liu, Meijing; Wang, Jia; Mou, Nan; Jiang, Erlie; Zhang, Rongli; Deng, Qi

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231158155
6、Elevated Angiotensin-II Levels Contribute to the Pathogenesis of Open-Angle Glaucoma Via Inducing the Expression of Fibrosis-Related Genes in Trabecular Meshwork Cells Through a ROS/NOX4/SMAD3 Axis
Author: Li, Haijun; Cui, Huiling; Ren, Jing; Wang, Di; Zhao, Rumeng; Zhu, Shichao; Liu, Siqing; Liu, Xiaohui; Tian, Shuai; Zhang, Yuanyuan; Zhao, Panpan; Li, Peng; Thorne, Rick F.; Duan, Shichao

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231162526
7、Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig
Author: Kobayashi, Yoshiomi; Shigyo, Michiko; Platoshyn, Oleksandr; Marsala, Silvia; Kato Jr, Tomohisa; Takamura, Naoki; Yoshida, Kenji; Kishino, Akiyoshi; Bravo-Hernandez, Mariana; Juhas, Stefan; Juhasova, Jana; Studenovska, Hana; Proks, Vladimir; Driscoll, Shawn P.; Glenn, Thomas D.; Pfaff, Samuel L.; Ciacci, Joseph D.; Marsala, Martin

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897221107009
8、Clinical Outcomes by Consolidation of Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Graft in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-analysis
Author: Jiang, Yinhao; Yang, Ziying; Shao, Lianbo; Shen, Han; Teng, Xiaomei; Chen, Yihuan; Ding, Yinglong; Fan, Jiaming; Yu, You; Shen, Zhenya

Journal: CELL TRANSPLANTATION. 2023; Vol. 32, Issue , pp. -. DOI: 10.1177/09636897231152381